Marcio Souza - 14 Nov 2022 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Executive Officer, Director
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
14 Nov 2022
Net transactions value
+$3,830
Form type
4
Filing time
21 Nov 2022, 05:07:00 UTC
Previous filing
25 Aug 2022
Next filing
13 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Award $3,830 +2,115 +1.1% $1.81 191,299 14 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).